|
US20030068322A1
(en)
*
|
1988-04-18 |
2003-04-10 |
Immunomedics, Inc. |
Methods of antibody-directed enzyme-prodrug therapy
|
|
US5846741A
(en)
*
|
1992-08-21 |
1998-12-08 |
Immunomedics, Inc. |
Boron neutron capture therapy using pre-targeting methods
|
|
US6228362B1
(en)
|
1992-08-21 |
2001-05-08 |
Immunomedics, Inc. |
Boron neutron capture therapy using pre-targeting methods
|
|
US6172045B1
(en)
*
|
1994-12-07 |
2001-01-09 |
Neorx Corporation |
Cluster clearing agents
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
|
WO1999024077A2
(en)
*
|
1997-11-10 |
1999-05-20 |
Cytimmune Sciences, Inc. |
Compositions and methods for targeted delivery of biologically-active factors
|
|
US6670194B1
(en)
*
|
1998-08-25 |
2003-12-30 |
University Of Washington |
Rapid quantitative analysis of proteins or protein function in complex mixtures
|
|
US6361774B1
(en)
*
|
1999-09-17 |
2002-03-26 |
Immunomedics, Inc. |
Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
|
|
US6629040B1
(en)
|
1999-03-19 |
2003-09-30 |
University Of Washington |
Isotope distribution encoded tags for protein identification
|
|
EP1187637A2
(en)
|
1999-06-07 |
2002-03-20 |
Center For Molecular Medicine And Immunology |
Alpha or beta emitters attached to fragments in radioimmunotherapy
|
|
AU6689401A
(en)
|
2000-06-12 |
2001-12-24 |
Univ Washington |
Selective labeling and isolation of phosphopeptides and applications to proteomeanalysis
|
|
DE60129741T2
(de)
*
|
2000-06-20 |
2008-04-30 |
Immunomedics, Inc. |
Zielgerichtete kombinationsimmuntherapie für krebs und infektionskrankheiten
|
|
KR100377946B1
(ko)
*
|
2000-07-15 |
2003-03-29 |
한국과학기술원 |
덴드리머를 이용한 단분자막의 제조방법
|
|
US7445802B2
(en)
*
|
2000-12-26 |
2008-11-04 |
Yeda Research And Development Co. Ltd |
Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases
|
|
US6500630B2
(en)
*
|
2001-01-12 |
2002-12-31 |
Mayo Foundation For Medical Education And Research |
Marker for inflammatory conditions
|
|
EP1372741B1
(en)
*
|
2001-03-30 |
2006-08-09 |
University of Massachusetts |
Morpholino imaging and therapy
|
|
WO2002098897A2
(en)
|
2001-06-01 |
2002-12-12 |
Cornell Research Foundation, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
EP1427377A4
(en)
|
2001-09-20 |
2006-04-12 |
Cornell Res Foundation Inc |
METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING SKIN DISORDERS USING SPECIFIC BINDING AGENTS FOR A PROSTATE-SPECIFIC MEMBRANE ANTIGEN
|
|
CA2475247C
(en)
*
|
2002-02-07 |
2015-08-04 |
Massachusetts Institute Of Technology |
Anti-pathogen treatments
|
|
US20030157091A1
(en)
*
|
2002-02-14 |
2003-08-21 |
Dyax Corporation |
Multi-functional proteins
|
|
JP2006502091A
(ja)
*
|
2002-03-01 |
2006-01-19 |
イミューノメディクス、インコーポレイテッド |
クリアランス速度を高めるための二重特異性抗体点変異
|
|
WO2004062722A2
(en)
*
|
2003-01-08 |
2004-07-29 |
Sloan Kettering Institute For Cancer Research |
Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers
|
|
ATE408712T1
(de)
|
2003-01-10 |
2008-10-15 |
Millennium Pharm Inc |
Verfahren zur bestimmung des wiederauftretens von prostata krebs
|
|
WO2005026325A2
(en)
*
|
2003-09-10 |
2005-03-24 |
Surromed, Inc, |
Bivalent targeting of cell surfaces
|
|
US20050260131A1
(en)
*
|
2004-05-20 |
2005-11-24 |
General Electric Company |
Pharmaceuticals for enhanced delivery to disease targets
|
|
US20060057062A1
(en)
*
|
2004-09-10 |
2006-03-16 |
Trotter Dinko G |
Compositions and methods useful in pretargeted imaging
|
|
EP1716870A1
(en)
*
|
2005-04-29 |
2006-11-02 |
Bracco Imaging S.p.A. |
MRI contrast agents endowed with concentration independent responsiveness
|
|
US20070009435A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Syud Faisal A |
Compositions and methods for enhanced delivery to target sites
|
|
US20070010014A1
(en)
*
|
2005-07-06 |
2007-01-11 |
General Electric Company |
Compositions and methods for enhanced delivery to target sites
|
|
US20070009428A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Syud Faisal A |
Compounds and methods for enhanced delivery to disease targets
|
|
US20070009427A1
(en)
*
|
2005-07-06 |
2007-01-11 |
Syud Faisal A |
Compounds and methods for enhanced delivery to disease targets
|
|
WO2007070680A2
(en)
*
|
2005-12-16 |
2007-06-21 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Optically detectable probes for identification and treatment of tumors
|
|
DE602007013215D1
(de)
*
|
2006-06-14 |
2011-04-28 |
Basf Se |
Antimikrobielle zusammensetzungen
|
|
IL182956A0
(en)
*
|
2007-05-03 |
2008-01-20 |
Yeda Res & Dev |
Glycan modified soluble receptors and binding proteins and their use
|
|
WO2009041037A1
(ja)
*
|
2007-09-26 |
2009-04-02 |
Japan As Represented By The President Of National Cardiovascular Center |
体内に存在する病因物質の低下剤
|
|
GB0916749D0
(en)
|
2009-09-23 |
2009-11-04 |
Mologic Ltd |
Peptide cleaning agents
|
|
US9850296B2
(en)
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
EP2603520A4
(en)
|
2010-08-10 |
2014-02-19 |
Ecole Polytech |
ERYTHROCYTE BINDING THERAPEUTICS
|
|
US9517257B2
(en)
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
JP5992435B2
(ja)
|
2010-12-21 |
2016-09-14 |
コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． |
循環からの生体分子の除去剤
|
|
US20140256639A1
(en)
*
|
2013-02-14 |
2014-09-11 |
The Regents Of The University Of California |
Peptoid neutralizing agents
|
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
SG11201606761RA
(en)
|
2014-02-21 |
2016-09-29 |
Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto |
Glycotargeting therapeutics
|
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
|
EP3154587B1
(en)
|
2014-06-13 |
2020-01-15 |
Tenboron OY |
Conjugates comprising an anti-egfr1 antibody
|
|
WO2018232176A1
(en)
|
2017-06-16 |
2018-12-20 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
|
US20230097887A1
(en)
|
2018-04-09 |
2023-03-30 |
Yale University |
Bi-functional Molecules to Degrade Circulating Proteins
|
|
US12485178B2
(en)
|
2018-04-09 |
2025-12-02 |
Yale University |
Bifunctional small molecules to target the selective degradation of circulating proteins
|
|
EP3773727A4
(en)
*
|
2018-04-09 |
2022-05-04 |
Yale University |
BIFUNCTIONAL SMALL MOLECULES TO TARGETING THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS
|
|
WO2019199621A1
(en)
*
|
2018-04-09 |
2019-10-17 |
Yale University |
Bi-functional molecules to degrade circulating proteins
|
|
EP3790577A4
(en)
|
2018-05-09 |
2022-04-27 |
The University of Chicago |
COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE
|
|
WO2021155317A1
(en)
|
2020-01-31 |
2021-08-05 |
Avilar Therapeutics, Inc. |
Asgpr-binding compounds for the degradation of extracellular proteins
|
|
CA3195446A1
(en)
|
2020-10-16 |
2022-04-21 |
Amelie Eriksson Karlstrom |
Pna probes for pretargeted imaging and therapy
|
|
KR20240017423A
(ko)
|
2021-05-03 |
2024-02-07 |
아빌라 테라퓨틱스, 인크. |
이뮤노글로불린 및 다른 단백질의 분해를 위한 강력한 asgpr-결합 화합물
|
|
TW202600606A
(zh)
*
|
2024-02-21 |
2026-01-01 |
美商雅博得樂醫療公司 |
抗體連接子結合物
|
|
WO2026024644A1
(en)
|
2024-07-23 |
2026-01-29 |
Abdera Therapeutics Inc. |
5t4 binding polypeptides and uses thereof
|